ONC — BeOne Medicines
Median target
$419
calls from the last 12 months
Implied return
+18.5%
median target vs. price
Coverage
16 analysts · 19 calls
updated in the last 12 months
Consensus
16/0/0+16 net
Buy / Hold / Sell
Which analysts are behind ONC's consensus?
See every current rating, price target and the analysts' track records for BeOne Medicines — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 16 analysts with calls on ONC updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
ONC elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-08 | Insiders | Wang XiaodongDirector | Insider sale | 10.7K sh @ $349.28 · planned trade | $3.7M |
| 2026-09-08 | Insiders | Wang XiaodongDirector | Insider sale | 7.5K sh @ $348.31 · planned trade | $2.6M |
| 2026-09-08 | Insiders | Wang XiaodongDirector | Insider sale | 6.6K sh @ $350.27 · planned trade | $2.3M |
| 2026-09-08 | Insiders | Wang XiaodongDirector | Insider sale | 6.3K sh @ $351.25 · planned trade | $2.2M |
| 2026-09-08 | Insiders | Wang XiaodongDirector | Insider sale | 2.8K sh @ $346.16 · planned trade | $983K |
| 2026-09-08 | Insiders | Wang XiaodongDirector | Insider sale | 1.7K sh @ $348.01 · planned trade | $599K |
| 2026-09-08 | Insiders | Wang XiaodongDirector | Insider sale | 1.5K sh @ $347.39 · planned trade | $527K |
| 2026-09-08 | Insiders | Wang XiaodongDirector | Insider sale | 1.2K sh @ $345.38 · planned trade | $408K |
| 2026-09-08 | Insiders | Xiaodong Wang | Proposed sale | 131.4K units · 0.23% of shares outstanding | $47.1M |
| 2026-09-01 | Insiders | Ball Titus B.Principal Accounting Off | Insider sale | 132 sh @ $355.86 | $47K |
More: insider activity · executive branch · trending